Jeremy P. Segal

MD, PhD

Jeremy Segal, MD, PhD is an Associate Professor of Pathology and the Director of the Division of Genomic and Molecular Pathology at The University of Chicago.  Dr. Segal received an MD from Weill Cornell Medical College and a PhD in Genetics from Rockefeller University, and completed Anatomic Pathology training at New York Hospital – Weill Cornell and Molecular Genetic Pathology training at the Hospital of the University of Pennsylvania.  After training, he worked at the New York Genome Center as Director of Clinical Development and Policy before joining the faculty at the University of Chicago.  Dr. Segal specializes in genomics technologies and bioinformatics, and has been chiefly responsible for the development of the Division of Genomic and Molecular Pathology, including creation of the Clinical Genomics Laboratory and development/validation of its oncology testing assays.  Test platforms in service at UChicago include large-scale DNA and RNA sequencing systems to support personalized cancer care and clinical trial recruitment.  Dr. Segal’s research interests revolve around novel use of genomics technologies to improve diagnostics and drive biomarker development, with current areas of interest including minimal residual disease assays and emerging epigenetics applications.